Zahed Subhan Email & Phone Number
@email.wcu.edu
LinkedIn matched
Who is Zahed Subhan? Overview
A concise factual answer block for searchers comparing this professional profile.
Zahed Subhan is listed as Professor at Drexel University, based in Greater Philadelphia, United States, United States. AeroLeads shows a work email signal at email.wcu.edu and a matched LinkedIn profile for Zahed Subhan.
Zahed Subhan previously worked as Executive Chairman, Co-founder and Director at Eppin Pharma Inc. and Co-Founder, Director at Aestas Pharma Inc.. Zahed Subhan holds Phd, Pharmacology from University Of Leeds.
Email format at Drexel University
This section adds company-level context without repeating Zahed Subhan's masked contact details.
AeroLeads found 1 current-domain work email signal for Zahed Subhan. Compare company email patterns before reaching out.
About Zahed Subhan
•Pharmaceutical and biopharmaceutical development and commercialization executive with more than 25 years experience in multinational and emerging pharmaceutical companies.•Extensive experience in drug discovery, clinical development, sales, marketing (including major drug launches), biopharmaceutical company start up and financing (seed, grants, venture capital), business development, licensing, alliance management and M&A.•Experienced in gaining regulatory approvals from FDA and EMA agencies.•Outstanding communication, presentation, teaching and negotiation skills.•Drexel University Professor; former University of North Carolina System Professor
Listed skills include Biotechnology, Commercialization, Drug Development, Biopharmaceuticals, and 22 others.
Zahed Subhan's current company
Company context helps verify the profile and gives searchers a useful next step.
Zahed Subhan work experience
A career timeline built from the work history available for this profile.
Executive Chairman, Co-Founder And Director
CurrentProfessor
Current
Co-Founder, Director
CurrentAestas Pharma Inc. is a pioneering biopharmaceutical company dedicated to the development of novel diagnostic imaging and therapeutic agents to enable the early detection and reversal of severely debilitating Alzheimer’s disease (AD). In marked contrast to competitor approaches, including current development stage drugs and diagnostics, Aestas is focused.
Co-Founder, Director, Ceo
Director of emerging biopharmaceutical company focused on the development of a first in class non-hormonal oral, reversible male contraceptive. Candidate compounds inhibit eppin-SEMG interaction and mimic anti-eppin, effectively inhibiting sperm motility.
Advisory Council Member
Professor
Member of faculty with broad academic responsibilities including responsibility for development and delivery of Healthcare Innovation Management program (Mission Health System, NC).
Member Of The Board Of Directors
Member of the board of directors of Arbovax Inc., developing unique technology to modify arthropod-borne viruses (arboviruses) preventing replication in mammalian cells.
Chief Business Officer (Consulting)
Head of Business Development & Marketing for dual preclinical CRO and emerging drug development company focused on metabolic disease and CNS therapeutic areas.
Ceo
- Assisted academic founders at the University of Pennsylvania with formation and financing of University of Pennsylvania start up company, with focus on cancer drug/diagnostic development.
- Developed first in class receptor targeted therapeutic agent for the treatment of hormone resistant prostate cancer and advanced metastatic breast cancer (receptor targeted therapeutic agent with potential superiority.
- Successfully advanced development through IND and phase II clinical trials.
- Completed seed, series A and follow-on financing from venture capital investors to fund development activities.
Ceo
- Chief Executive Officer of emerging biopharmaceutical company focused on "DNA-directed" synthesis of small molecule drug candidates using proprietary "Chemetics" technology platform.
- Advanced early stage platform technology to generate pre-clinical drug candidates as potential cancer and CNS therapeutics raising $18MM in VC funding.Company acquired by Amgen
Vp Business Development & Marketing
Responsible for worldwide business development for emerging US drug Discovery Company focused on CNS, cancer and inflammation (structure based drug design technology platform).
Chief Business Officer
- Responsible for worldwide business development & licensing, technology transfer and patents/IP management for EU and US based Genomics/Clinical Genetics Company with emphasis on disease gene identification.
- Negotiated licensing and research collaborations with major healthcare and pharmaceutical companies in US, EU and Japan.
- Key member of Executive Management Team achieving $100 MM IPO on NASDAQ stock exchange and $220 MM trade sale to Sequenom Inc. (CA, USA).
European Marketing Director; Head Of Sales And Marketing, Head Of Business Development
- Launched major pharmaceutical brands including Celexa® (depression), Sinemet® CR® (Parkinson's disease), Tiazac® (angina), Zestril® (hypertension).
- Leadership of professional business development, and marketing teams, including sales, professional (medical) relations, alliance management, licensing, product management, marketing planning, marketing communications.
- Recruited, trained and developed field sales and professional relations teams to achieve corporate revenue and earnings objectives.
Product Manager - Imitrex®
Launched first in class treatment for migraine: Imitrex® (sumatriptan).
Clincal Research Manager; Sales Representative
Coordinated phase II/III neurology (epilepsy) clinical drug development programs to FDA requirements.
Clinical Trials Coordinator
- Supervised conduct of phase I-II clinical trials in pharmaceutical industry sponsored university based clinical pharmacology unit.
- Completed doctorate (PhD) in Pharmacology. Published 30 articles in peer reviewed academic journals.
Zahed Subhan education
Phd, Pharmacology
Mba, Marketing & Strategic Management
Llb (Honors), Law
Ms, Applied Experimental Psychology And Neuroscience
Bs (Honors), Pharmacology
Frequently asked questions about Zahed Subhan
Quick answers generated from the profile data available on this page.
What company does Zahed Subhan work for?
Zahed Subhan works for Drexel University.
What is Zahed Subhan's role at Drexel University?
Zahed Subhan is listed as Professor at Drexel University.
What is Zahed Subhan's email address?
AeroLeads has found 1 work email signal at @email.wcu.edu for Zahed Subhan at Drexel University.
Where is Zahed Subhan based?
Zahed Subhan is based in Greater Philadelphia, United States, United States while working with Drexel University.
What companies has Zahed Subhan worked for?
Zahed Subhan has worked for Drexel University, Eppin Pharma Inc., Aestas Pharma Inc., Eppin Pharma Inc, and North Carolina Biotechnology Center (Western North Carolina Region).
How can I contact Zahed Subhan?
You can use AeroLeads to view verified contact signals for Zahed Subhan at Drexel University, including work email, phone, and LinkedIn data when available.
What schools did Zahed Subhan attend?
Zahed Subhan holds Phd, Pharmacology from University Of Leeds.
What skills is Zahed Subhan known for?
Zahed Subhan is listed with skills including Biotechnology, Commercialization, Drug Development, Biopharmaceuticals, Entrepreneurship, Management, Life Sciences, and Pharmaceutical Industry.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial